Latest from Kromek

After a busy and successful DSEI 2025, the Kromek team kept up momentum and attended several events and exhibitions across the UK and Europe throughout the autumn months.

Kromek’s CEO, Arnab Basu, talks with BBC News about the Chancellor’s Budget: discussing the absence of defence in the budget, the impact on SME growth, employment and investment, as well as the effects on conducting business on national and international levels.

Kromek's CEO, Dr Arnab Basu, recently spoke with BBC Radio Tees about the work being done by the Kromek team and partners to make breast cancer screening technology more effective for women with dense breasts.

Ground-breaking breast cancer imaging research developed in the North East has been showcased on the international stage, as the latest results from the project were presented at one of the world’s leading medical imaging conferences in Yokohama, Japan.

Kromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces its final results for the year ended 30 April 2025.

Kromek Group plc, the leading developer of advanced radiation detection technology, will sponsor the breakfast in the MAKE UK Defence pavilion (N4-110, from 0830-0900, Wed - Fri) at the international defence and security exhibition DSEI 2025 at the Excel Centre, London, next week (9-11 September 2025).